Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 223 results found. Search for [ doses of COVID-19 vaccines ]

Results 1 to 21 of 223
PTI
October 20, 2020
The agency said as soon as COVID-19 vaccines successfully emerge from trials and are licensed and recommended for use, the world will need as many syringes as doses of vaccine


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


Rashi Bisaria
New Delhi, October 19, 2020
Reliance Jio plans to sells 5G smartphones at Rs 2,500-3,000Reliance Jio is planning to launch a 5G smartphone for less than Rs 5,000 and gradually reduce the price to Rs 2,500-3,000 a unit when it scales up the operation, according to a company official. The company will target 20-30 crore mobile phone users who use 2G connection at present.Coronavirus impact: Passenger vehicle exports dip 57.52% in Apr-SepPassenger vehicle exports bore the brunt of the pandemic in April-September period....


PTI
October 17, 2020
Modi insisted on continued social distancing and COVID-appropriate behaviour such as wearing masks, regularly washing hands and sanitation, especially during upcoming festival season


BusinessToday.In
New Delhi, October 17, 2020
COVID-19 led to largest global economic contraction in 80 years: World Bank, IMFThe World Bank and the International Monetary Fund said the global economic contraction caused by the ongoing coronavirus pandemic is the largest in the last eight decades, raising the world poverty rate, exacerbating inequalities and damaging long-term economic growth prospects. The WB and IMF concluded their annual meeting here on Friday, which heavily revolved around the impact of COVID-19.India gained over a...


PB Jayakumar
October 16, 2020
India may get COVID-19 vaccine by March 2021 provided the regulators signal with the processes fast as multiple manufacturers are working on it, and already two are in phase-3 trial and one in the phase-2 trial


Reuters
October 16, 2020
China has said that while reasonable profits for companies are permitted, COVID-19 vaccines should be priced close to cost


PTI
October 16, 2020
A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years


BusinessToday.In
October 15, 2020
Apollo Hospitals Group Executive Vice-Chairperson Shobana Kamineni said that the group will work with the government in tandem to ensure that maximum number of people gets the coronavirus vaccine safe and fast


Joe C Mathew
October 15, 2020
Civil society groups say there is an inequality of access to critical technologies that are needed to address the pandemic; they want WTO member countries to unequivocally support the adoption of the IP Waiver proposal


BusinessToday.In
October 15, 2020
According to World Health Organisation's chief scientist, Dr Soumya Swaminathan said, health workers, elderly and frontline workers might get the COVID-19 vaccine first, though the prioritisation details are still being worked out by the WHO


Associated Press
October 15, 2020
We now need to increase production of the first vaccine and the second vaccine, Russian President Vladimir Putin said, adding that the priority was to supply the Russian market with the vaccines


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months


Reuters
October 12, 2020
The government did not disclose financial terms of the deal, its first vaccine purchase, which will provide enough doses to vaccinate 750,000 people


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


Reuters
October 8, 2020
Several European countries have said they are experiencing shortages of the drug, whose global stock has been secured almost entirely by the United States


BusinessToday.In
October 8, 2020
Future cost of the COVID-19 vaccine could become a contentious issue. Some pharma companies have said they can't produce vaccine on a non-profit basis, while others like AstraZeneca and Johnson & Johnson will provide doses on a \"cost basis\" during COVID-19 pandemic


Associated Press
October 7, 2020
The Treasury and Health Departments developed economic modelling based on an assumption that a vaccine would be widely available in Australia toward the end of next year, Treasurer Josh Frydenberg said


Reuters
October 7, 2020
Nine experimental vaccines are in the pipeline of the WHO's COVAX global vaccine facility that aims to distribute 2 billion doses by the end of 2021


Rashi Bisaria
New Delhi, October 5, 2020
BT MPW 2020: Aadhaar can be leveraged to vaccinate population en masse, says Kiran Mazumdar ShawAs the whole world is waiting for coronavirus vaccine, technology can play a pivotal and vital role in how the government vaccinates its population, tracks vaccines, monitors doses, and also manages to locate any adverse events, says Kiran Mazumdar Shaw, chairperson & MD, Biocon. Speaking at the Business Today's India's Most Powerful Women 2020, Mazumdar Shaw further states that if India gets ...


PAGES 1 OF 12  12345